Published 19:17 IST, April 26th 2022
COVAXIN gets DCGI nod for kids aged 6-12; Bharat Biotech assures it is 'safe, efficacious'
The DCGI has granted restricted emergency use authorisation for Bharat Biotech's COVAXIN for children in the age group of six to twelve years. Read further.
Image: PTI | Image:
self
- Listen to this article
- 3 min read
Advertisement
19:17 IST, April 26th 2022